guest ::
| Home > Publications database > Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. > print |
| Home > Publications database > Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. > print |
| 001 | 182814 | ||
| 005 | 20240229145732.0 | ||
| 024 | 7 | _ | |a 10.1016/j.radonc.2022.11.015 |2 doi |
| 024 | 7 | _ | |a pmid:36442608 |2 pmid |
| 024 | 7 | _ | |a 0167-8140 |2 ISSN |
| 024 | 7 | _ | |a 1879-0887 |2 ISSN |
| 024 | 7 | _ | |a altmetric:139941361 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-02946 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Heumann, Philipp |0 P:(DE-He78)dd2a4cfd38fcbd0112e8b6cb387b6753 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2023 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1673509868_7010 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:C020#LA:C020# / Volume 178, January 2023, 109426 |
| 520 | _ | _ | |a Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer patients.Analyses were made of data from 1,756 prostate cancer patients treated with external beam radiotherapy (RT) and/or brachytherapy in Europe and the USA and recruited into the prospective multicentre observational REQUITE study. Eleven pelvic symptoms at the end of RT were compared after translating patient-reported outcomes (PROs) into CTCAE-based healthcare professional ratings. Gwet's AC2 agreement coefficient and 95% confidence intervals were calculated for each symptom. To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were graphically depicted. Stratified and sensitivity analyses were conducted to identify potential influencing factors and to assess heterogeneity and robustness of results.The agreement for the 11 pelvic symptoms varied from very good (AC2>0.8: haematuria, rectal bleeding, management of sphincter control) to poor agreement (AC2≤0.2: urinary frequency fair, proctitis and urinary urgency). Fatigue had a negative impact on the agreement. Patients tended to grade symptoms more severely than healthcare professionals. Information on sexual dysfunction was missing more frequently in healthcare professional assessment than PROs.Agreement was better for observable than subjective symptoms, with patients usually grading symptoms more severely than healthcare professionals. Our findings emphasize that PROs should complement symptom assessment by healthcare professionals and be taken into consideration for clinical decision-making to incorporate the patient perspective. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a adverse events |2 Other |
| 650 | _ | 7 | |a agreement |2 Other |
| 650 | _ | 7 | |a patient-reported outcomes |2 Other |
| 650 | _ | 7 | |a prostate cancer |2 Other |
| 650 | _ | 7 | |a radiotherapy |2 Other |
| 700 | 1 | _ | |a Aguado-Barrera, Miguel E |b 1 |
| 700 | 1 | _ | |a Avuzzi, Barbara |b 2 |
| 700 | 1 | _ | |a Azria, David |b 3 |
| 700 | 1 | _ | |a Briers, Erik |b 4 |
| 700 | 1 | _ | |a Bultijnck, Renée |b 5 |
| 700 | 1 | _ | |a Choudhury, Ananya |b 6 |
| 700 | 1 | _ | |a De Ruysscher, Dirk |b 7 |
| 700 | 1 | _ | |a Farcy-Jacquet, Marie-Pierre |b 8 |
| 700 | 1 | _ | |a Fonteyne, Valérie |b 9 |
| 700 | 1 | _ | |a Gómez Caamaño, Antonio |b 10 |
| 700 | 1 | _ | |a Helmbold, Irmgard |0 P:(DE-He78)6463d23a85ce9e7ecc93b32fc2b4d25f |b 11 |u dkfz |
| 700 | 1 | _ | |a Johnson, Kerstie |b 12 |
| 700 | 1 | _ | |a Kerns, Sarah L |b 13 |
| 700 | 1 | _ | |a Lambrecht, Maarten |b 14 |
| 700 | 1 | _ | |a Lingard, Zoe |b 15 |
| 700 | 1 | _ | |a Rancati, Tiziana |b 16 |
| 700 | 1 | _ | |a Rosenstein, Barry |b 17 |
| 700 | 1 | _ | |a Sperk, Elena |b 18 |
| 700 | 1 | _ | |a Paul Symonds, R. |b 19 |
| 700 | 1 | _ | |a Talbot, Christopher |b 20 |
| 700 | 1 | _ | |a Valdagni, Riccardo |b 21 |
| 700 | 1 | _ | |a Vega, Ana |b 22 |
| 700 | 1 | _ | |a Veldeman, Liv |b 23 |
| 700 | 1 | _ | |a Ward, Tim |b 24 |
| 700 | 1 | _ | |a Webb, Adam |b 25 |
| 700 | 1 | _ | |a West, Catharine |b 26 |
| 700 | 1 | _ | |a Chang-Claude, Jenny |0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |b 27 |u dkfz |
| 700 | 1 | _ | |a Seibold, Petra |0 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215 |b 28 |e Last author |u dkfz |
| 700 | 1 | _ | |a Consortium, REQUITE |b 29 |e Collaboration Author |
| 773 | _ | _ | |a 10.1016/j.radonc.2022.11.015 |g p. S0167814022045637 |0 PERI:(DE-600)1500707-8 |p 109426 |t Radiotherapy and oncology |v 178 |y 2023 |x 0167-8140 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:182814 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)dd2a4cfd38fcbd0112e8b6cb387b6753 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)6463d23a85ce9e7ecc93b32fc2b4d25f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 28 |6 P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-31 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-31 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-21 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b RADIOTHER ONCOL : 2022 |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-21 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b RADIOTHER ONCOL : 2022 |d 2023-10-21 |
| 920 | 2 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|